Israel Active

Israel’s TailorMed (see previously) helps financially at-risk patients access resources in the US such as co-pay assistance, replacement medicine programs, government subsidies, community funds, state or disease-specific foundations, and programs that help with living expenses.

Israel’s NanoVation (see previously) has been awarded a 5 million Euro grant from the European Innovation Council (EIC) on top of the 2.5 million Euro grant it received last year from Europe’s Horizon 2020 program. It will accelerate the development of NanoVation’s high accuracy respiratory monitor.

Laparoscopic (keyhole) removal of the uterus risks spreading possibly cancerous tissue, to other parts of the body. But the LapBox system from Israel’s Ark Surgical ensures secure organ retrieval.

Six years ago (see previously) Technion scientists began developing a sensing plaster to detect tuberculosis biomarkers on the skin. Now, trials of the A-Patch, in India and South Africa, have showed high effectiveness. TB affects around one third of the world’s population.

A great summary of the work that Weizmann scientists have been conducting on the microbiome (bacteria in the gut) that led to the founding of startup DayTwo. Diabetics can now have their gut microbiome analyzed and receive a personalized nutrition plan. (2016 video still relevant – 3 million views)

United Hatzalah held a dedication ceremony for its new Dr. Miriam and Sheldon G. Adelson Ambucycle Unit. Dr Miriam donated 150 ambucycles (motorcycle ambulances), in the memory of Sheldon, to join the 1,000 existing vehicles used in their emergency paramedic work.

Israel’s Montfort (see previously) has launched a new version of its smartphone app, called “Brain Profiler” to diagnose psychosis, depression and anxiety. It will be sent to the International Space Station in 2022 to test and monitor Israel’s Eytan Stibbe and his fellow astronauts.

Jerusalem’s Shaare Zedek hospital is piloting the diagnosis of blood cancer using cutting-edge AI technology from Israel’s Sight Diagnostics (see previously). Data and images from Sight’s OLO device, plus patient data can identify malignant lymphocytes and spot early hematological cancer.

The N9 portable home device from Israel’s Nonagon (previously MyHomeDoc reported ) now includes stethoscope (lung, heart etc. sounds); otoscope (ears); oximeter (pulse and oxygen) and thermometer. It also uses patient’s smartphone camera (throat & skin tests).

Israel’s DiA Imaging is partnering Canada’s Circle Cardiovascular Imaging (CCI). DiA’s AI Ultrasound imaging analysis systems will be integrated into CCI’s cardiovascular imaging equipment.